1. A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy – results from a Swedish cohort study. Issue 1 (December 2016) Authors: Jiang, Xia; Askling, Johan; Saevarsdottir, Saedis; Padyukov, Leonid; Alfredsson, Lars; Viatte, Sebastien; Frisell, Thomas Journal: Arthritis research & therapy Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study. Issue 5 (13th January 2022) Authors: Mongin, Denis; Lauper, Kim; Finckh, Axel; Frisell, Thomas; Courvoisier, Delphine Sophie Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 5(2022) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10 365 general population men. (4th November 2014) Authors: Lundholm, Lena; Frisell, Thomas; Lichtenstein, Paul; Långström, Niklas Journal: Addiction Issue: Volume 110:Number 1(2015:Jan.) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Apgar Score Components at 5 Minutes: Risks and Prediction of Neonatal Mortality. Issue 4 (11th May 2017) Authors: Cnattingius, Sven; Norman, Mikael; Granath, Fredrik; Petersson, Gunnar; Stephansson, Olof; Frisell, Thomas Journal: Paediatric and perinatal epidemiology Issue: Volume 31:Issue 4(2017:Jul.) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease. Issue 10 (8th February 2016) Authors: Michaud, Kaleb; Berglind, Niklas; Franzén, Stefan; Frisell, Thomas; Garwood, Christopher; Greenberg, Jeffrey D; Ho, Meilien; Holmqvist, Marie; Horne, Laura; Inoue, Eisuke; Nyberg, Fredrik; Pappas, Dimitrios A; Reed, George; Symmons, Deborah; Tanaka, Eiichi; Tran, Trung N; Verstappen, Suzanne M M;... Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 10(2016) Page Start: 1797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients. Issue 5 (9th March 2020) Authors: Alping, Peter; Askling, Johan; Burman, Joachim; Fink, Katharina; Fogdell‐Hahn, Anna; Gunnarsson, Martin; Hillert, Jan; Langer‐Gould, Annette; Lycke, Jan; Nilsson, Petra; Salzer, Jonatan; Svenningsson, Anders; Vrethem, Magnus; Olsson, Tomas; Piehl, Fredrik; Frisell, Thomas Journal: Annals of neurology Issue: Volume 87:Issue 5(2020) Page Start: 688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Carryover Effects in Sibling Comparison Designs. Issue 6 (November 2016) Authors: Sjölander, Arvid; Frisell, Thomas; Kuja-Halkola, Ralf; Öberg, Sara; Zetterqvist, Johan Journal: Epidemiology Issue: Volume 27:Issue 6(2016:Nov.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data. Issue 4 (23rd June 2022) Authors: Barbulescu, Andrei; Askling, Johan; Saevarsdottir, Saedis; Kim, Seoyoung C.; Frisell, Thomas Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 4(2022) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply. (5th March 2019) Authors: Frisell, Thomas; Askling, Johan Journal: Rheumatology Issue: Volume 58:Number 8(2019) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply. (5th May 2019) Authors: Frisell, Thomas; Askling, Johan Journal: Rheumatology Issue: Volume 58:Number 8(2019) Page Start: 1510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗